바이오테크 보도자료
-
- Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
- Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under developm...
- 03월 18일 16:38
-
- DNA Script Expands Global Access to On-demand DNA Synthesis With Distributor Agreements in Latin America and East Asia
- DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell , Bio-Medical Science Co. (BMS...
- 03월 18일 15:55
-
- GCE® Launches Gascontrol.com Website Showcasing Its Complete Gas Control Portfolio for Speciality, Medical, and Industrial Applications
- GCE®, a global market leader for gas control equipment, has launched gascontrol.com , a new website designed to better serve customers across its GCE Specialty, GCE Medical, and GCE Industrial product portfo...
- 03월 18일 11:25
-
- Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay
- H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL B...
- 03월 17일 16:20
-
- AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies
- Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & Anti‑Aging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics portfolio,...
- 03월 17일 16:00
-
- Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide
- Samsung Bioepis Co., Ltd. and Epis NexLab Co., Ltd., a sister company to Samsung Bioepis under Samsung Epis Holdings (KRX: 0126Z0), today announced a research collaboration and license agreement with G2GBIO,...
- 03월 16일 09:23
-
- C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests to Help Doctors Diagnose Alzheimer’s Disease
- C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain Healthcare that brings its breakthrough diagnostic te...
- 03월 13일 15:55
-
- Andersen Consulting Strengthens Platform with Collaborating Firm Ambit Iberia
- Andersen Consulting expands its technology and business transformation capabilities through a Collaboration Agreement with Ambit Iberia, a consulting firm specializing in digital and regulatory solutions for...
- 03월 13일 11:40
-
- Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets
- Veristat , a global clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to international pharmaceutical and medical...
- 03월 12일 16:10
-
- InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice
- InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The anno...
- 03월 12일 15:55
-
- IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Application Lab
- IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production and innovation capabilities to better support the continued growth of it...
- 03월 12일 15:30
-
- Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
- Chiesi Group (“Chiesi”), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today an...
- 03월 12일 08:36
전시회
